Media

HealthCap´s co-founder Peder Fredrikson passed away at the age of 72

BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q1 2024

Oncopeptides publishes prospectus relating to the rights issue

Oncopeptides secures national reimbursement for Pepaxti in Spain

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

Fusion Pharmaceuticals Announces Presentation Of Interim Data From The Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 At The AACR Annual Meeting 2024

Vivet Therapeutics Doses First Patient in Cohort 2 in Phase 1/2 GATEWAY Clinical Trial for Treatment of Wilson Disease

Oncopeptides announces final terms for the fully guaranteed rights issue

Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2024

Ariceum Therapeutics to present new radioligand therapy data at American Association for Cancer Research (AACR) Annual Meeting 2024